Filomena Russo

24PUBLICATIONS
32CO-AUTHORS
PharmacogenomicsAllergyPharmaceutical delivery technologiesInternational trade and investment lawSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 13, 2024
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study.

Marco Galluzzo, Emanuele Trovato, Marina Talamonti

|Apr 26, 2024
Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores Between Different Phenotypes of Atopic Dermatitis in Patients Before and After Biologic Therapy With Dupilumab.

Filomena Russo, Vittoria Cioppa, Laura Lazzeri

|Mar 12, 2024
Dupilumab in real-life settings: a review of adverse events and their pathogenesis.

Elisa Camela, Anna Rita Giampetruzzi, Ornella De Pità

|Dec 18, 2023
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.

Filomena Russo, Marco Galluzzo, Luca Stingeni

|Apr 10, 2023
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study.

Marina Talamonti, Filomena Russo, Giovanna Malara

|Mar 14, 2023
Exploring the Relationship Between Dermatology Life Quality Index, Eczema Area and Severity Index, and Sleep Numerical Rating Scale and Pruritus Numerical Rating Scale in Patients with Atopic Dermatitis Treated with Dupilumab.

Filomena Russo, Vittoria Cioppa, Alessandra Cartocci

Pageof 4

Frequent Collaborators

3 joint publications

Giulio Cortonesi

3 joint publications

Francesco Santi

2 joint publications

Nicoletta Bernardini

2 joint publications

Elisa Camela